Navigation Links
MRSA in hospital intensive care -- what's growing where?
Date:3/30/2008

Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today (Monday 31 March 2008) at the Society for General Microbiologys 162nd meeting being held this week at the Edinburgh International Conference Centre.

We are developing a standard sampling regime to take swabs from sinks, taps, floors and other surfaces like computer keyboards, and use these to identify accurately which superbug genes are present in an intensive care unit, says Gemma Kay from Sheffield Hallam University in South Yorkshire. Critically ill patients in the intensive care unit are particularly at risk from hospital acquired infections.

The university research team has been working with clinical collaborators at the Sheffield Teaching Hospitals Trust to develop infection control procedures which could protect vulnerable patients and help to manage any future superbug outbreaks.

Our technique allows us to characterise the genes from micro-organisms using a gene amplification technique called polymerase chain reaction (PCR). This lets us expand tiny samples enough to identify individual strains of bacteria, and to spot particular antibiotic resistance genes, says Gemma Kay.

Our findings so far, from routine samples taken from the intensive care unit and patients screened over the last 12 months, show extremely low levels of MRSA (methicillin resistant Staphylococcus aureus), known drug resistant bacteria such as Clostridium difficile and other strains of bacteria that can make extended spectrum beta lactamase, which are all resistant to antibiotics commonly used to treat infections, says Gemma Kay.

Patients in intensive care units are particularly vulnerable to drug resistant infections, which can worsen their condition, prolong their stay and require heavy antibiotic regimes, diverting significant resources from the hospital budget. To date frequencies of resistant infections in the intensive care unit have been extremely low.

By establishing which organisms and which drug resistance genes are circulating in the intensive care unit we will be able to see to what extent the environment is a potential infection threat to patients, says Gemma Kay. Our experience so far suggests very good infection control, but the final outcomes of the study may suggest further changes that could provide additional protection for patients.


'/>"/>

Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
44-011-898-81843
Society for General Microbiology
Source:Eurekalert

Related biology news :

1. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
2. Pennsylvania Hospital recognized for excellence in bariatric surgery
3. Childrens Hospital neurosurgeon receives grant
4. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
5. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
6. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
7. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology
8. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
9. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
10. Will intensive forest practices impact water quality?
11. Research project aims to control sunlight, extend growing season and conserve energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
Breaking Biology Technology: